This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Stemme, S. Search for Related Content PubMed PubMed Citation Articles by Stemme, S.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1099.)
© 2001 American Heart Association, Inc.

Editorial

Plaque T-Cell Activity

Not So Specific?

Sten Stemme

From the Cardiovascular Research Unit, Center for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.

Correspondence to Sten Stemme, MD, PhD, Cardiovascular Research Unit, Center for Molecular Medicine L8:03, Karolinska Hospital, S-171 76 Stockholm, Sweden. E-mail sten.stemme@cmm.ki.se

The notion that atherosclerosis has an inflammatory component was already proposed in the 19th century by Virchow, on the basis of light microscopic analysis of human plaques. The hypothesis was later supported by electron microscopic studies and was confirmed when immunohistochemical analysis revealed that the CD14+ macrophage indeed was the major cell type in the plaque.^{1 2} More surprising was the finding that T lymphocytes were also present in substantial numbers in human plaques.¹ The presence of cellular representatives of the specific, adaptive immune system in this disease has since then inspired a whole area of research, and our knowledge has certainly grown. T lymphocytes are designed to perform effector functions after activation by a specific antigen via the T-cell receptor. A first obvious question was, therefore, what these antigen-specific cells might be reactive to. Are there atherosclerosis-related antigens taking part in atherogenesis? This inquiry constitutes something of a "needle-in-a-haystack" problem, and the question of clonal composition is easier to address. The presence of clonal T-cell expansions would suggest reactivity to a limited number of antigens in early experimental atherosclerosis.³ More advanced human plaques, however, demonstrate a polyclonal T-cell composition.^{4 5} This characteristic does not constitute evidence that T cells are "nonspecific" (ie, are carrying reactivities not related to atherosclerosis), but it does suggest that no single antigen reactivity dominates the T-cell population. This result in itself is not surprising, because it is known from other inflammatory conditions, with known eliciting antigens, that antigen-specific cells in general constitute a minority of all . . . [Full Text of this Article]